Beranda › Penyakit Paru
Uji klinis Penyakit Paru yang merekrut di AS
57 studi untuk Penyakit Paru merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX15 studi
- Boston, MA14 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Pittsburgh, PA10 studi
- Miami, FL10 studi
- Washington, DC10 studi
- Dallas, TX10 studi
- Ann Arbor, MI10 studi
- Columbus, OH10 studi
- Nashville, TN10 studi
- Los Angeles, CA10 studi
- Chicago, IL9 studi
- Birmingham, AL9 studi
- Baltimore, MD8 studi
- Orlando, FL8 studi
- Philadelphia, PA8 studi
- Charleston, SC7 studi
- Seattle, WA7 studi
- Detroit, MI7 studi
- Cincinnati, OH7 studi
- Jacksonville, FL7 studi
- Tampa, FL7 studi
- Atlanta, GA7 studi
- St. Louis, MO6 studi
- Kansas City, KS6 studi
- Salt Lake City, UT6 studi
- Hialeah, FL5 studi
- Portland, OR5 studi
- Indianapolis, IN5 studi
- Winston-Salem, NC5 studi
- San Francisco, CA5 studi
- Oklahoma City, OK5 studi
- Arlington, VA5 studi
- Louisville, KY5 studi
- Newport Beach, CA4 studi
- Denver, CO4 studi
- Burlington, VT4 studi
- Tucson, AZ4 studi
- Cleveland, OH4 studi
Berdasarkan negara bagian
- Alabama13 studi
- Arizona9 studi
- California30 studi
- Colorado12 studi
- Distrik Columbia6 studi
- Florida26 studi
- Georgia11 studi
- Hawaii3 studi
- Idaho3 studi
- Illinois16 studi
- Indiana5 studi
- Kansas9 studi
- Kentucky9 studi
- Louisiana5 studi
- Maryland13 studi
- Massachusetts15 studi
- Michigan17 studi
- Minnesota7 studi
- Missouri8 studi
- Nebraska4 studi
- Nevada6 studi
- New Jersey6 studi
- New Mexico3 studi
- New York16 studi
- North Carolina18 studi
- Ohio18 studi
- Oklahoma5 studi
- Oregon5 studi
- Pennsylvania20 studi
- Rhode Island3 studi
- South Carolina11 studi
- Tennessee15 studi
- Texas22 studi
- Utah7 studi
- Vermont4 studi
- Virginia10 studi
- Washington8 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109Study of the Disease Process of Lymphangioleiomyomatosis
Menerima pesertaStudi observasional
Usia 16 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00001465Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01730092A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07489066American Lung Association (ALA) Lung Health Cohort
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 25 hingga 35 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551Study of Lung Proteins in Patients With Pneumonia
Menerima pesertaStudi observasional
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00077909A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06977581A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07407933Role of Genetic Factors in the Development of Lung Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 90 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT00001532A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06572384A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05967689Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05624450A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07745907A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Menerima pesertaFase 2
Usia 4 hingga 11 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07525375Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07776353A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07555483Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.